Objective-In this article, we studied the effect of acetyl-11-keto--boswellic acid (AKBA), a natural inhibitor of the proinflammatory transcription factor NF-B on the development of atherosclerotic lesions in apolipoprotein E-deficient (apoE Ϫ/Ϫ ) mice. Methods and Results-Atherosclerotic lesions were induced by weekly LPS injection in apoE Ϫ/Ϫ mice. LPS alone increased atherosclerotic lesion size by Ϸ100%, and treatment with AKBA significantly reduced it by Ϸ50%. Moreover, the activity of NF-B was also reduced in the atherosclerotic plaques of LPS-injected apoE Ϫ/Ϫ mice treated with AKBA. As a consequence, AKBA treatment led to a significant downregulation of several NF-B-dependent genes such as MCP-1, MCP-3, IL-1␣, MIP-2, VEGF, and TF. By contrast, AKBA did not affect the plasma concentrations of triglycerides, total cholesterol, antioxidized LDL antibodies, and various subsets of lymphocytederived cytokines. Moreover, AKBA potently inhibited the IB kinase (IKK) activity immunoprecipitated from LPS-stimulated mouse macrophages and mononuclear cells leading to decreased phosphorylation of IB␣ and inhibition of p65/NF-B activation. Comparable AKBA-mediated inhibition was also observed in LPS-stimulated human macrophages.
Conclusion-The